gptkb:APR-246
|
gptkb:myelodysplastic_syndromes
|
gptkb:Lapatinib
|
gptkb:HER2-positive_breast_cancer
|
gptkb:cladribine
|
gptkb:relapsing_forms_of_multiple_sclerosis
|
gptkb:sorafenib_tosylate
|
advanced renal cell carcinoma
|
gptkb:Brentuximab_vedotin
|
relapsed or refractory Hodgkin lymphoma
|
gptkb:Metoprolol_Succinate
|
thyrotoxicosis
|
gptkb:Ultomiris
|
chronic kidney disease
|
gptkb:Pataday_eye_drops
|
perennial allergic conjunctivitis
|
gptkb:Dapagliflozin/_Metformin/_NPH
|
glycemic control
|
gptkb:USRobotics_56_KV.92_PCI_Modem
|
gptkb:Yes
|
gptkb:5_stars
|
highly acclaimed performance
|
gptkb:Fabrazyme
|
enzyme deficiency
|
gptkb:Movantik
|
Chronic pain patients on opioids
|
gptkb:sunitinib
|
neuroendocrine tumors
|
gptkb:Ciprodex
|
otitis media with effusion
|
gptkb:SDG_7
|
Energy intensity measured in terms of primary energy and GDP
|
gptkb:Keytruda
|
small cell lung cancer
|
gptkb:Nexo_Brid
|
eschar removal
|
gptkb:imiglucerase
|
acute type 1 Gaucher disease
|
gptkb:Allegra-D
|
Nasal congestion
|